Results 81 to 90 of about 459,727 (225)

Molecular epidemiology of meningococcal disease in Northern Ghana [PDF]

, 2001
Meningococcal disease remains a major public health concern, especially in the African Meningitis Belt where large meningitis epidemics with attack rates of up to 500/100,000 recur every 8-12 years.
Gagneux, Sébastien
core   +1 more source

Immunogenicity and safety of meningococcal vaccines, MenACWY-CRM and 4CMenB, in groups at increased risk for meningococcal disease

Expert Review of Vaccines
Introduction Individuals with immunocompromising conditions (e.g. asplenia, complement deficiency, HIV infection) or with high exposure to Neisseria meningitidis (e.g.
Shravani Bobde, Chiranjiwi Bhusal, Catherine A. Cosgrove, Woo-Yun Sohn   +3 more
doaj   +1 more source

Safety and Immunogenicity of a Tetravalent Polysaccharide Vaccine Against Meningococcal Disease

Journal of the Formosan Medical Association, 2009
Meningococcal disease, including meningitis and sepsis, usually follows an invasive infection by Neisseria meningitidis, and is a major cause of death and morbidity worldwide.
Pei-Lan Shao, Luan-Yin Chang, Szu-Min Hsieh, Shan-Chwen Chang, Sung-Ching Pan, Chun-Yi Lu, Yu-Chia Hsieh, Chin-Yun Lee, Kurt Dobbelaere, Dominique Boutriau, Haiwen Tang, Hans L. Bock, Li-Min Huang   +12 more
doaj   +1 more source

Progress toward the global control of Neisseria meningitidis: 21st century vaccines, current guidelines, and challenges for future vaccine development

Human Vaccines & Immunotherapeutics, 2018
The control of meningitis, meningococcemia and other infections caused by Neisseria meningitidis is a significant global health challenge. Substantial progress has occurred in the last twenty years in meningococcal vaccine development and global ...
A. W. Dretler, N. G. Rouphael, D. S. Stephens   +2 more
doaj   +1 more source

Social Behavior and Meningococcal Carriage in British Teenagers

, 2006
Understanding predisposing factors for meningococcal carriage may identify targets for public health interventions. Before mass vaccination with meningococcal group C conjugate vaccine began in autumn 1999, we took pharyngeal swabs from ?14,000 UK ...
MacLennan, J., MacLennan, Jenny, Neal, K., Andrews, Nick, Kafatos, G, Cameron, J. Claire, J. Claire Cameron, Maiden, Martin C J, Kafatos, George, Keith Neal, Cann, Kathy, Evans, M.R., MacLennan, J, Cann, K, Kafatos, G., Cameron, JC, Roberts, Richard, Richard Roberts, Evans, MR, Nick Andrews, Martin C.J. Maiden, James M. Stuart, Evans, Meirion R., Neal, K, David N. Baxter, Maiden, MCJ, Stuart, J.M., Baxter, David N., Roberts, R., Cameron, J.C., Andrews, N., Maiden, M.C.J., Jenny MacLennan, Meirion R. Evans, George Kafatos, Kathy Cann, Andrews, N, Stuart, JM, Cann, K., Roberts, R, Baxter, DN, Stuart, James M., Baxter, D.N., Neal, Keith   +43 more
core   +2 more sources

Meningococcal Vaccines: Current Status and Emerging Strategies

Vaccines, 2018
Neisseria meningitidis causes most cases of bacterial meningitis. Meningococcal meningitis is a public health burden to both developed and developing countries throughout the world.
Pumtiwitt C. McCarthy, Abeer Sharyan, Laleh Sheikhi Moghaddam   +2 more
doaj   +1 more source

Meningococcal ACWY vaccine : what you need to know [PDF]

Meningococcal ACWY vaccine can help protect against meningococcal disease caused by serogroups A, C, W, and Y.

core  

What is the evidence for giving chemoprophylaxis to children or students attending the same preschool, school or college as a case of meningococcal disease? [PDF]

, 2011
We performed a systematic literature review to assess the effectiveness of chemoprophylaxis for contacts of sporadic cases of invasive meningococcal disease (IMD) in educational settings.
Heuberger, S., Stuart, J.M., G. HANQUET, Nielsen, Stine, Stefanoff, P., P. STEFANOFF, Hanquet, G, Hanquet, Germaine, S. HEUBERGER, Nielsen, S, J. M. STUART, W. HELLENBRAND, Stefanoff, P, Stuart, JM, Hellenbrand, Wiebke, Heuberger, S, S. NIELSEN, Hellenbrand, W, Hanquet, G.   +18 more
core   +1 more source

Trends in Meningococcal Disease in the United States Military, 1971–2010

Emerging Infectious Diseases, 2012
Meningococci have historically caused extensive illness among members of the United States military. Three successive meningococcal vaccine types were used from 1971 through 2010; overall disease incidence dropped by >90% during this period.
Michael P. Broderick, Dennis J. Faix, Christian J. Hansen, Patrick J. Blair   +3 more
doaj   +1 more source

Critical appraisal of a quadrivalent CRM197 conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo®) in the context of treatment and prevention of invasive disease

Infection and Drug Resistance, 2011
Michael Bröker, Brian Cooper, Lisa M DeTora, Jeffrey J StoddardGlobal Medical Affairs, Novartis Vaccines and Diagnostics, Marburg, Germany, and Cambridge, MA, USAAbstract: Worldwide, invasive meningococcal disease affects about 500,000 people ...
Bröker M, Cooper B, DeTora LM, Stoddard JJ   +3 more
doaj